Exploring the Anti-inflammatory and Immunomodulatory Properties of Crude Polysaccharides: A Comprehensive Review

Rosa Murata^*
*Correspondence: Rosa Murata, Department of Biochemistry, Tokyo University of Science, Tokyo 125-8585, Japan, Email:

Introduction

Inflammation and immune dysregulation underpin a vast array of diseases, ranging from autoimmune disorders to chronic inflammatory conditions and cancer. Over the years, extensive research has sought to unravel the complexities of these processes, leading to the identification of various therapeutic targets. Among these, natural compounds, particularly polysaccharides derived from diverse sources, have emerged as promising candidates due to their multifaceted biological activities and minimal adverse effects [1]. In this comprehensive review, we delve into the intricate interplay between inflammation and the immune system, focusing on the therapeutic potential of crude polysaccharides in modulating these processes. The immune system serves as a formidable defense mechanism, orchestrating a complex network of cells, signaling molecules and tissues to protect the host from pathogens and maintain tissue homeostasis. Central to this system is inflammation, a tightly regulated response characterized by the activation of immune cells and the release of pro-inflammatory mediators. While acute inflammation is essential for eliminating pathogens and initiating tissue repair, chronic inflammation can lead to tissue damage and contribute to the pathogenesis of various diseases, including rheumatoid arthritis, inflammatory bowel disease and cardiovascular disorders. Concurrently, the immune system operates under a delicate balance of activation and suppression, ensuring effective responses to pathogens while preventing autoimmunity and excessive tissue damage. Immunomodulation, the process of regulating immune responses, plays a critical role in maintaining this equilibrium. Dysregulation of immune function can result in autoimmune diseases, allergies and impaired host defense against infections [2].

Description

Amidst this backdrop, natural compounds have garnered attention for their ability to modulate inflammation and immune responses. Among them, polysaccharides, long-chain carbohydrates found abundantly in plants, fungi, algae and microorganisms, have emerged as promising candidates for therapeutic intervention. Crude polysaccharides, consisting of complex mixtures of polysaccharide molecules extracted from natural sources, offer a diverse array of bioactivities, including anti-inflammatory and immunomodulatory effects. The chemical structures of polysaccharides are highly variable, comprising repeating units of monosaccharides linked by glycosidic bonds. This structural diversity confers unique biological properties to polysaccharides, influencing their interactions with immune cells and inflammatory mediators. Extraction methods play a crucial role in isolating polysaccharides from natural sources while preserving their bioactive components. Common extraction techniques include hot water extraction, ethanol precipitation and enzymatic digestion, each with its advantages and limitations [3].

The anti-inflammatory properties of crude polysaccharides have been extensively studied in various experimental models and clinical settings. Mechanistically, polysaccharides exert their effects through multiple pathways, including inhibition of pro-inflammatory cytokines such as Tumor Necrosis Factor-Alpha (TNF-α) and Interleukin-6 (IL-6), modulation of Nuclear Factor-Kappa B (NF-κB) signaling and regulation of inflammatory enzymes like Cyclooxygenase-2 (COX-2) and Inducible Nitric Oxide Synthase (iNOS). Moreover, crude polysaccharides have been shown to modulate immune cell function, influencing the activity of macrophages, dendritic cells, Natural Killer (NK) cells and T lymphocytes. These interactions are pivotal in shaping innate and adaptive immune responses, enhancing antigen presentation and promoting immune surveillance against pathogens and cancer cells. Additionally, polysaccharides exhibit immunomodulatory effects on humoral and cellular immunity, including the regulation of antibody production, T cell proliferation and cytokine secretion. In preclinical studies, crude polysaccharides have demonstrated efficacy in ameliorating inflammation and immune dysregulation in various disease models, including rheumatoid arthritis, inflammatory bowel disease and allergic asthma. Furthermore, clinical trials have provided preliminary evidence supporting the therapeutic potential of polysaccharides in inflammatory conditions and immune-related disorders, albeit with some limitations in study design and standardization [4].

In addition to their therapeutic potential, crude polysaccharides also hold promise as functional food ingredients and dietary supplements for promoting immune health and preventing inflammatory conditions. Incorporating polysaccharide-rich foods and nutraceuticals into the diet may offer a natural approach to modulating immune function and mitigating the risk of chronic diseases. Furthermore, the development of functional food products fortified with standardized polysaccharide extracts could provide convenient and accessible options for consumers seeking to support their immune system and overall well-being. While the field of crude polysaccharide research has made significant strides in recent years, several avenues for future exploration and innovation remain. Elucidating the structure-activity relationships of polysaccharides, leveraging advanced analytical techniques such as Nuclear Magnetic Resonance (NMR) spectroscopy and mass spectrometry will enhance our understanding of their biological mechanisms and facilitate the rational design of polysaccharide-based therapeutics. Additionally, large-scale clinical trials with well-defined polysaccharide preparations and rigorous study designs are needed to establish the safety, efficacy and optimal dosing regimens of polysaccharide interventions across different patient populations and disease states [5].

Conclusion

Despite the growing evidence supporting the anti-inflammatory and immunomodulatory properties of crude polysaccharides, several challenges remain. Standardization of extraction methods, characterization of bioactive components and elucidation of structure-activity relationships are essential for ensuring the consistency and efficacy of crude polysaccharide-based therapies. Furthermore, additional preclinical and clinical studies are needed to evaluate the safety and efficacy of crude polysaccharides in different disease settings. Combination therapies involving crude polysaccharides with conventional drugs or other natural compounds may also hold promise for synergistic effects and improved therapeutic outcomes. In conclusion, crude polysaccharides exhibit significant anti-inflammatory and immunomodulatory properties, making them attractive candidates for the development of novel therapeutic agents. Their ability to modulate immune responses and regulate inflammatory processes holds promise for the treatment of various chronic diseases. Continued research efforts aimed at understanding their mechanisms of action and therapeutic potential are warranted to harness the full benefits of crude polysaccharides in clinical practice.

Acknowledgment

None.

Conflict of Interest

There are no conflicts of interest by author.

References

1. Hirayama, Daisuke, Tomoya Iida and Hiroshi Nakase. "The phagocytic function of macrophage-enforcing innate immunity and tissue homeostasis." Int J Mol Sci 19 (2017): 92.

Google Scholar, Crossref, Indexed at

2. Fioranelli, Massimo, Maria Grazia Roccia, Dana Flavin and Linda Cota. "Regulation of inflammatory reaction in health and disease." Int J Mol Sci 22 (2021): 5277.

Google Scholar, Crossref, Indexed at

3. Jaworowska, Agnieszka and Aliza Murtaza. "Seaweed derived lipids are a potential anti-inflammatory agent: A review." Int J Environ Res Public Health 20 (2022): 730.

 Google Scholar, Crossref, Indexed at

4. Yi, Lingxiao, Qi Wang, Haiyan Luo and Daqing Lei, et al. "Inhibitory effects of polyphenols-rich components from three edible seaweeds on inflammation and colon cancer in vitro." Front Nutr 9 (2022): 856273.

Google Scholar, Crossref, Indexed at

5. Adrien, Amandine, Antoine Bonnet, Delphine Dufou and Stanislas Baudouin, et al. "Anticoagulant activity of sulfated ulvan isolated from the green macroalga Ulva rigida." Mar Drugs 17 (2019): 291.

Google Scholar, Crossref, Indexed at